started · updated
Senate panel to vote on FDA commissioner nominee Heidi Overton
The Senate Committee on Health, Education, Labor, and Pensions is scheduled to vote on the nomination of Dr. Heidi Overton to lead the Food and Drug Administration during its November 18 session. Overton, a former White House adviser and board-certified physician, was nominated by President Donald Trump in August.
The nomination faces scrutiny from various political factions. Senator Bill Cassidy (R-La.) expressed uncertainty regarding his support, citing a lack of trust resulting from broken promises and irresponsible decisions by other administration officials. Additionally, Overton has faced criticism from pro-life activists regarding her stance on abortion pill safety reviews and from vaccine skeptics following her statements affirming the safety and effectiveness of approved vaccines.
Groups such as Americans for Contraception have launched advertising campaigns targeting Republican senators to oppose her nomination, citing concerns over intrauterine devices and abortion. The FDA has lacked Senate-confirmed leadership since the resignation of Dr. Marty Makary in May.
Entities
Bill Cassidy · Donald Trump · Food and Drug Administration · Heidi Overton · Senate Committee on Health, Education, Labor, and Pensions